# A Study of MHB039A for Advanced Solid Tumor

Source: https://onco.cc/trials/nct06345482/  
OnCo record `nct06345482` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of MHB039A in advanced solid tumours, run by Minghui Pharmaceutical (Hangzhou) Ltd, active and no longer recruiting.

## Summary

A Study of MHB039A for Advanced Solid Tumor is a phase 1/2 interventional study registered as NCT06345482 by Minghui Pharmaceutical (Hangzhou) Ltd, with 196 participants enrolled, started 2024-04-16 and due to reach its primary completion in 2028-04-01. Interventions recorded: MHB039A.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT06345482
- Phase: 1/2
- Setting: A Phase I/II Study of MHB039A for Advanced Solid Tumor to Evaluate the Efficacy and Safety
- Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd
- Enrolled: 196

## Sources

- ClinicalTrials.gov NCT06345482: https://clinicaltrials.gov/study/NCT06345482

## Connected records

- cancers: [Metastatic cancer (cancer that has spread)](https://onco.cc/cancers/metastatic-cancer/)
- drugs: [MHB039A](https://onco.cc/drugs/mhb039a/)

---
JSON: https://onco.cc/api/v1/entities/nct06345482.json